Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

about

Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 - 2014).Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.The COPD Pipeline XXIX.

P2860

Q38478442-B64F879A-9ED6-4C24-87D8-86772A7E5B36 Q38882099-103F60A6-37EF-40DF-97CA-2481A56D53B5 Q41399925-D81E55DB-2384-4C83-BDD8-B8B5973282FC

P2860

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

Item

http://www.wikidata.org/entity/Q54309065

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@en

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@nl

type

Item

label

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@en

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@nl

prefLabel

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@en

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@nl

P1476

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

@en

P2093

Peter Norman

http://www.w3.org/2001/XMLSchema#string

P2860

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

Design and synthesis of inhaled p38 inhibitors for the treatment of chronic obstructive pulmonary disease

A pyrrolo-pyrimidine derivative targets human primary AML stem cells in vivo

Identification of Hck inhibitors as hits for the development of antileukemia and anti-HIV agents.

Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness

An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.

p38 mitogen-activated protein kinase pathways in asthma and COPD.

What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?

Spleen tyrosine kinase inhibitors: a review of the patent literature 2010 - 2013.

Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial.

P304

1397-1407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2014.967213

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25407284

http://www.w3.org/2001/XMLSchema#string

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

about

P2860

P2860

Respivert's multikinase inhibitors, an evaluation of WO2014033446 to WO2014033449.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698